America's GMO firms face China hurdle
Chinese consumer wariness over GMO safety has risen of late, and at the same time, Chinese regulatory approvals have ground to a near halt
Kansas City, Missouri
WITH US approval for Dow AgroSciences' package of chemicals and new genetically engineered crops now in hand, the Dow Chemical Co unit faces a major obstacle to a US$1 billion market opportunity: Chinese import barriers.
The Asian nation has become a major buyer of US corn and soyabeans in recent years, but has also shown mounting reluctance to accept some genetically modified crops grown by US farmers. China for the last year has been rejecting US corn shipments containing traces of a type of GMO corn developed by Syngenta AG.
Now Dow, which, like Syngenta has yet to rec…
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Energy & Commodities
Asia: Oil surges, equities sink as Iran blasts fan Middle East escalation fears
Gold set for fifth weekly gain as geopolitical risks buoy demand
Oil holds near 3-week low as US sanctions interrupt easing tensions
Seatrium unit ordered to pay US$108 million in arbitration over equipment supply contracts
BP reshapes its leadership team as some executives leave
BHP to decide on future of nickel business by August, trims met coal estimates